Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.
Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W; Schizophrenia Patient Outcomes Research Team (PORT). Buchanan RW, et al. Among authors: boggs dl. Schizophr Bull. 2010 Jan;36(1):71-93. doi: 10.1093/schbul/sbp116. Epub 2009 Dec 2. Schizophr Bull. 2010. PMID: 19955390 Free PMC article. Review.
Reaching for wellness in schizophrenia.
Kelly DL, Boggs DL, Conley RR. Kelly DL, et al. Among authors: boggs dl. Psychiatr Clin North Am. 2007 Sep;30(3):453-79. doi: 10.1016/j.psc.2007.04.003. Psychiatr Clin North Am. 2007. PMID: 17720032 Review.
The effects of galantamine on psychopathology in chronic stable schizophrenia.
Conley RR, Boggs DL, Kelly DL, McMahon RP, Dickinson D, Feldman S, Ball MP, Buchanan RW. Conley RR, et al. Among authors: boggs dl. Clin Neuropharmacol. 2009 Mar-Apr;32(2):69-74. doi: 10.1097/WNF.0B013E31816F2795. Clin Neuropharmacol. 2009. PMID: 18978489 Free PMC article. Clinical Trial.
Cigarette smoking and mortality risk in people with schizophrenia.
Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim JC, Love RC, Dixon L. Kelly DL, et al. Among authors: boggs dl. Schizophr Bull. 2011 Jul;37(4):832-8. doi: 10.1093/schbul/sbp152. Epub 2009 Dec 17. Schizophr Bull. 2011. PMID: 20019128 Free PMC article.
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Kelly DL, et al. Among authors: boggs dl. J Clin Psychopharmacol. 2011 Feb;31(1):86-91. doi: 10.1097/JCP.0b013e318204825b. J Clin Psychopharmacol. 2011. PMID: 21192149 Free PMC article. Clinical Trial.
37 results